Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community
- PMID: 22370857
- PMCID: PMC3321117
- DOI: 10.1097/EDE.0b013e31824cb93b
Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community
Abstract
Background: We assessed the association between perfluorooctanoic acid (PFOA) and pregnancy outcome in an area with elevated exposure to PFOA from drinking water contaminated by chemical plant releases.
Methods: Serum PFOA was measured, and reproductive and residential histories were obtained during 2005-2006. We estimated serum PFOA levels at the time of pregnancy for 11,737 pregnancies occurring between 1990 and 2006, based on historical information on PFOA releases, environmental distribution, pharmacokinetic modeling, and residential histories. We assessed the association between PFOA and the odds of miscarriage, stillbirth, preeclampsia, preterm birth, term low birthweight, and birth defects, controlling for calendar time, age, parity, education, and smoking. PFOA exposure was evaluated as a continuous measure (with and without log transformation) and in quintiles, combining the lowest 2 quintiles (< 6.8 ng/mL) as the referent.
Results: Measures of association between PFOA and miscarriage, preterm birth, term low birthweight, and birth defects were close to the null. Odds of stillbirth were elevated in the fourth quintile only. For preeclampsia, the odds ratio was 1.13 (95% confidence interval = 1.00-1.28) for an interquartile shift in log-transformed PFOA, and the odds ratios were 1.1-1.2 across the upper 3 quintiles of exposure.
Conclusions: In this large, population-based study in a region with markedly elevated PFOA exposure, we found no associations between estimated serum PFOA levels and adverse pregnancy outcomes other than possibly preeclampsia. Conclusions are tempered by inherent limitations in exposure reconstruction and self-reported pregnancy outcome information.
Similar articles
-
Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome.Am J Epidemiol. 2009 Oct 1;170(7):837-46. doi: 10.1093/aje/kwp212. Epub 2009 Aug 19. Am J Epidemiol. 2009. PMID: 19692329
-
Perfluorooctanoic acid exposure and thyroid disease in community and worker cohorts.Epidemiology. 2014 Mar;25(2):255-64. doi: 10.1097/EDE.0000000000000040. Epidemiology. 2014. PMID: 24407430
-
Early life perfluorooctanoic acid (PFOA) exposure and overweight and obesity risk in adulthood in a community with elevated exposure.Environ Res. 2014 Jul;132:62-9. doi: 10.1016/j.envres.2014.03.025. Epub 2014 Apr 16. Environ Res. 2014. PMID: 24742729
-
Tenuous dose-response correlations for common disease states: case study of cholesterol and perfluorooctanoate/sulfonate (PFOA/PFOS) in the C8 Health Project.Drug Chem Toxicol. 2011 Oct;34(4):396-404. doi: 10.3109/01480545.2011.582502. Epub 2011 Jul 19. Drug Chem Toxicol. 2011. PMID: 21770727 Review.
-
Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: a critical review of recent literature.Environ Res. 2012 Jul;116:93-117. doi: 10.1016/j.envres.2012.03.007. Epub 2012 May 4. Environ Res. 2012. PMID: 22560884 Review.
Cited by
-
Per- and polyfluoroalkyl substances in drinking water and hypertensive disorders of pregnancy in the United States during 2013-2015.Environ Epidemiol. 2022 May 4;6(3):e209. doi: 10.1097/EE9.0000000000000209. eCollection 2022 Jun. Environ Epidemiol. 2022. PMID: 35702500 Free PMC article.
-
Early-pregnancy plasma per- and polyfluoroalkyl substance (PFAS) concentrations and hypertensive disorders of pregnancy in the Project Viva cohort.Environ Int. 2022 Jul;165:107335. doi: 10.1016/j.envint.2022.107335. Epub 2022 Jun 6. Environ Int. 2022. PMID: 35696844 Free PMC article.
-
Evaluating maternal exposure to an environmental per and polyfluoroalkyl substances (PFAS) mixture during pregnancy: Adverse maternal and fetoplacental effects in a New Zealand White (NZW) rabbit model.Sci Total Environ. 2022 Sep 10;838(Pt 4):156499. doi: 10.1016/j.scitotenv.2022.156499. Epub 2022 Jun 6. Sci Total Environ. 2022. PMID: 35679923
-
Association Between Exposure to Per- and Polyfluoroalkyl Substances and Birth Outcomes: A Systematic Review and Meta-Analysis.Front Public Health. 2022 Mar 24;10:855348. doi: 10.3389/fpubh.2022.855348. eCollection 2022. Front Public Health. 2022. PMID: 35400049 Free PMC article.
-
Using Live Imaging and FUCCI Embryonic Stem Cells to Rank DevTox Risks: Adverse Growth Effects of PFOA Compared With DEP Are 26 Times Faster, 1,000 Times More Sensitive, and 13 Times Greater in Magnitude.Front Toxicol. 2021 Nov 30;3:709747. doi: 10.3389/ftox.2021.709747. eCollection 2021. Front Toxicol. 2021. PMID: 35295126 Free PMC article.
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
Full Text Sources
Medical
